Literature DB >> 10694486

Comprehensive gene expression profile of a normal human liver.

T Yamashita1, S Hashimoto, S Kaneko, S Nagai, N Toyoda, T Suzuki, K Kobayashi, K Matsushima.   

Abstract

To investigate the gene expression profile of a normal human liver, we performed serial analysis of gene expression (SAGE), which allows the quantitative and simultaneous analysis of thousands of genes expressed in tissue. Polyadenylated RNA was obtained from a bulk normal human liver sample and SAGE was performed. Reverse transcriptase-polymerase chain reaction (RT-PCR) was also performed in each of 3 different normal liver samples to evaluate the validity of the profile in each individual. A total of 30,982 tags were sequenced, 8,596 of which were unique. The genes highly expressed in the normal liver were those encoding plasma proteins (>21.8% of total transcripts), cytoplasmic proteins (>8.6%), enzymes (>4.8%), protease inhibitors (>1.7%), complements (>1.1%), and coagulation factors (>0.75%). About 13.9% of all transcripts encoded genes not reported in GenBank thus far. This study identifies candidate genes to be examined in relation to various human liver diseases, including viral hepatitis, liver cirrhosis, and hepatocellular carcinoma. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10694486     DOI: 10.1006/bbrc.2000.2272

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Analysis of circadian liver gene expression by ADDER, a highly sensitive method for the display of differentially expressed mRNAs.

Authors:  B Kornmann; N Preitner; D Rifat; F Fleury-Olela; U Schibler
Journal:  Nucleic Acids Res       Date:  2001-06-01       Impact factor: 16.971

2.  Identification of the IFITM3 gene as an inhibitor of hepatitis C viral translation in a stable STAT1 cell line.

Authors:  L Yao; H Dong; H Zhu; D Nelson; C Liu; L Lambiase; X Li
Journal:  J Viral Hepat       Date:  2011-03-16       Impact factor: 3.728

3.  Mechanisms of Evolutionary Innovation Point to Genetic Control Logic as the Key Difference Between Prokaryotes and Eukaryotes.

Authors:  William Bains; Dirk Schulze-Makuch
Journal:  J Mol Evol       Date:  2015-07-25       Impact factor: 2.395

4.  Serial analysis of gene expression in Plasmodium falciparum reveals the global expression profile of erythrocytic stages and the presence of anti-sense transcripts in the malarial parasite.

Authors:  S Patankar; A Munasinghe; A Shoaibi; L M Cummings; D F Wirth
Journal:  Mol Biol Cell       Date:  2001-10       Impact factor: 4.138

5.  Genes involved in oxidative phosphorylation are coordinately upregulated with fasting hyperglycaemia in livers of patients with type 2 diabetes.

Authors:  H Misu; T Takamura; N Matsuzawa; A Shimizu; T Ota; M Sakurai; H Ando; K Arai; T Yamashita; M Honda; T Yamashita; S Kaneko
Journal:  Diabetologia       Date:  2006-12-23       Impact factor: 10.122

6.  Assessment of nutritional status and prediction of postoperative liver function from serum apolioprotein A-1 levels with hepatectomy.

Authors:  Tadashi Katsuramaki; Toru Mizuguchi; Masaki Kawamoto; Kouji Yamaguchi; Makoto Meguro; Minoru Nagayama; Takayuki Nobuoka; Yasutoshi Kimura; Tomohisa Furuhata; Koichi Hirata
Journal:  World J Surg       Date:  2006-10       Impact factor: 3.352

Review 7.  Application of serial analysis of gene expression to the study of human genetic disease.

Authors:  Martin P Horan
Journal:  Hum Genet       Date:  2009-07-10       Impact factor: 4.132

8.  Massive-scale RNA-Seq analysis of non ribosomal transcriptome in human trisomy 21.

Authors:  Valerio Costa; Claudia Angelini; Luciana D'Apice; Margherita Mutarelli; Amelia Casamassimi; Linda Sommese; Maria Assunta Gallo; Marianna Aprile; Roberta Esposito; Luigi Leone; Aldo Donizetti; Stefania Crispi; Monica Rienzo; Berardo Sarubbi; Raffaele Calabrò; Marco Picardi; Paola Salvatore; Teresa Infante; Piergiuseppe De Berardinis; Claudio Napoli; Alfredo Ciccodicola
Journal:  PLoS One       Date:  2011-04-20       Impact factor: 3.240

9.  The hepatic transcriptome in human liver disease.

Authors:  Nicholas A Shackel; Devanshi Seth; Paul S Haber; Mark D Gorrell; Geoffrey W McCaughan
Journal:  Comp Hepatol       Date:  2006-11-07

10.  Individualized treatment of chronic hepatitis C with pegylated interferon and ribavirin.

Authors:  Roberto J Carvalho-Filho; Olav Dalgard
Journal:  Pharmgenomics Pers Med       Date:  2010-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.